Delhimed.com

Delhimed. We as a Company are driven by its Core Values & culture built by the company. We are a customer centric organization working towards...

Never miss Delhimed.com updates: Start reading the news feed of Delhimed right away! Unfortunately, we cannot detect RSS feed on this website, but you may observe related news or Delhimed.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Delhimed

Subscribe to related news

Marketing Executive - Prosthodontic / Volt / Loughborough, Leicestershire, United Kingdom
via jobs.adpulp

Volt/Loughborough, Leicestershire, United Kingdom Marketing Executive - Loughborough - £30,000 per annum + depending on experience - 12 Month Contract Our client a Global manufacturing company is seeking a Marketing Executive to be based in Loughborough...
Bay Gardens Resorts discontinues use of ESP products
via stlucianewsonline

The post Bay Gardens Resorts discontinues use of ESP products appeared first on St. Lucia News Online. PRESS RELEASE – The Green Globe certified resort chain, Bay Gardens Resorts has discontinued the use all Expanded Polystyrene (EPS) products throughout...
EWE Consulting Engineers: Unexampled Engineering Solutions
via insightssuccess

Bar for “Plant Engineering” is set very high. It stands in the need of wide ranging knowledge and experience in process, machinery, codes, control systems and project management. It depends on the client’s considerations and approach to plan and design...
APMT uses NSF funding to develop biopharmaceutical stability technology
via flowcontrolnetwork

Advanced Polymer Monitoring Technologies Inc. (APMT) received funding from the National Science Foundation‘s Small Business Innovation Research program to develop technology for biopharmaceutical analysis. The $1.1 million funding supports the development...
Granules India - Initiating Coverage - Achieving higher altitude in performance: Centrum
via indiaer.blogspot

Rating: Buy; Target Price: Rs720; CMP: Rs545; Upside: 32% Achieving higher altitude in performance We initiate coverage on Granules India (GIL) with a Buy recommendation. GIL has a unique business model with its presence over the entire pharma value...